TABLE 3.
Frequency of pathogens in respiratory tract cultures from hospitalized patients
| Entire cohort N = 6,367 |
ICU N = 1,823 |
||||||
|---|---|---|---|---|---|---|---|
| Community-acquired LRTI (no healthcare exposure) N = 1,395 |
Community-acquired LRTI (with healthcare exposure) N = 2,212 |
LRTI diagnosed 3–7 days after admission N = 2,760 |
Community-acquired LRTI (no healthcare exposure) N = 454 |
Community-acquired LRTI (with healthcare exposure) N = 426 |
LRTI diagnosed 3–7 days after admission N = 943 |
||
|
Streptococcus pneumoniae N (%) |
176 (12.6) | 141 (6.4) | 95 (3.4) |
Streptococcus pneumoniae N (%) |
91(20) | 43 (10.1) | 32 (3.4) |
|
Stenotrophomonas, Acinetobacter N (%) |
69 (4.9) | 161 (7.3) | 315 (11.4) |
Stenotrophomonas, Acinetobacter N (%) |
24 (5.3) | 31 (7.3) | 151 (16) |
|
Staphylococcus aureus N (%) |
227 (16.3) | 354 (16) | 407 (14.8) |
Staphylococcus aureus N (%) |
89 (18.9) | 70 (16.4) | 98 (10.4) |
|
Serratia, Providencia, Proteus N (%) |
66 (4.7) | 173 (7.8) | 225 (8.2) |
Serratia, Providencia, Proteus N (%) |
19 (4.2) | 27 (6.3) | 77 (8.2) |
|
Pseudomonas species, Burkholderia N (%) |
210 (15.1) | 539 (24.4) | 556 (22.1) |
Pseudomonas species, Burkholderia N (%) |
32 (7) | 51 (12) | 174 (18.5) |
|
Haemophilus influenzae, Bordetella spp., Moraxella spp. N (%) |
276 (19.8) | 280 (12.7) | 302 (10.2) |
Haemophilus influenzae, Bordetella spp., Moraxella spp. N (%) |
89 (19.6) | 92 (21.6) | 87 (9.2) |
|
Citrobacter, Enterobacter, K. pneumoniae, E. coli N (%) |
371 (26.6) | 564 (25.5) | 860 (31.2) |
Citrobacter, Enterobacter, K. pneumoniae, E. coli N (%) |
113 (24.9) | 112 (26.3) | 324 (34.3) |